Saltar al contenido

Merck & Co., Inc. (MRK) stock: revenue, earnings & dividend

Merck & Co., Inc. (MRK, NYSE): revenue, earnings, dividend and balance sheet from official SEC filings.

Stock screener MRK · NYSE Pharma & Biotech US-NJ

Key figures

Fiscal year
2025
Revenue
65 bn $
Revenue growth
1.3 %
Revenue growth 5y (p.a.)
9.4 %
Net income
18.3 bn $
Net margin
28.1 %
Operating margin
–
Earnings per share (diluted)
7.28 $
Dividend per share
3.28 $
Payout ratio
45.1 %
Consecutive dividend years
17 years
Consecutive dividend raises
15 years
Dividend growth 5y (p.a.)
5.8 %
Total assets
137 bn $
Equity
52.6 bn $
Equity ratio
38.4 %
Return on equity
34.7 %
Cash
14.6 bn $
Operating cash flow
16.5 bn $
Free cash flow
12.4 bn $
Shares outstanding
2,465,245,688

History

Revenue by fiscal year

2016 39.8 bn $
2017 40.1 bn $
2018 42.3 bn $
2019 39.1 bn $
2020 41.5 bn $
2021 48.7 bn $
2022 59.3 bn $
2023 60.1 bn $
2024 64.2 bn $
2025 65 bn $

Net income by fiscal year

2016 3.92 bn $
2017 2.39 bn $
2018 6.22 bn $
2019 9.84 bn $
2020 7.07 bn $
2021 12.3 bn $
2022 14.5 bn $
2023 365 m $
2024 17.1 bn $
2025 18.3 bn $

Dividend per share

2016 1.85 $
2017 1.89 $
2018 1.99 $
2019 2.26 $
2020 2.48 $
2021 2.64 $
2022 2.80 $
2023 2.96 $
2024 3.12 $
2025 3.28 $
YearRevenueNet incomeEPSDividend per shareOperating cash flow
202565 bn $18.3 bn $7.28 $3.28 $16.5 bn $
202464.2 bn $17.1 bn $6.74 $3.12 $21.5 bn $
202360.1 bn $365 m $0.14 $2.96 $13 bn $
202259.3 bn $14.5 bn $5.71 $2.80 $19.1 bn $
202148.7 bn $12.3 bn $5.14 $2.64 $–
202041.5 bn $7.07 bn $2.78 $2.48 $10.3 bn $
201939.1 bn $9.84 bn $3.81 $2.26 $13.4 bn $
201842.3 bn $6.22 bn $2.32 $1.99 $10.9 bn $
201740.1 bn $2.39 bn $0.87 $1.89 $6.45 bn $
201639.8 bn $3.92 bn $1.41 $1.85 $10.4 bn $

Data from XBRL filings at the SEC, processed automatically, no guarantee. Not investment advice. All filings at the SEC (EDGAR)